학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 14건 | 목록
1~20
Academic Journal
de Jong J; a Janssen Research & Development , San Diego , CA , USA.; Skee D; b Janssen Research & Development , Raritan , NJ , USA.; Hellemans P; c Janssen Research & Development , Beerse , Belgium.; Jiao J; b Janssen Research & Development , Raritan , NJ , USA.; de Vries R; c Janssen Research & Development , Beerse , Belgium.; Swerts D; c Janssen Research & Development , Beerse , Belgium.; Lawitz E; d Texas Liver Institute, University of Texas Health Science Center San Antonio , TX , USA.; Marbury T; e Orlando Clinical Research Center , Orlando , FL , USA.; Smith W; f New Orleans Center for Clinical Research , Knoxville , TN , USA.; Sukbuntherng J; g Pharmacyclics LLC , Sunnyvale , CA , USA.; Mannaert E; c Janssen Research & Development , Beerse , Belgium.
Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE
Academic Journal
de Vries R; Janssen Research & Development, Beerse, Belgium.; Smit JW; Janssen Research & Development, Beerse, Belgium.; Hellemans P; Janssen Research & Development, Beerse, Belgium.; Jiao J; Janssen Research & Development, Raritan, NJ, USA.; Murphy J; Janssen Research & Development, Raritan, NJ, USA.; Skee D; Janssen Research & Development, Raritan, NJ, USA.; Snoeys J; Janssen Research & Development, Beerse, Belgium.; Sukbuntherng J; Pharmacyclics, Inc., Sunnyvale, CA, USA.; Vliegen M; Janssen Research & Development, Beerse, Belgium.; de Zwart L; Janssen Research & Development, Beerse, Belgium.; Mannaert E; Janssen Research & Development, Beerse, Belgium.; de Jong J; Janssen Research & Development, San Diego, CA, USA.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Academic Journal
de Jong J; Janssen Research & Development, LLC, La Jolla, 3210 Merryfield Row, San Diego, CA, 92121, USA, jdejong1@its.jnj.com.; Sukbuntherng J; Skee D; Murphy J; O'Brien S; Byrd JC; James D; Hellemans P; Loury DJ; Jiao J; Chauhan V; Mannaert E
Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Academic Journal
Moreau P; Karamanesht II; Domnikova N; Kyselyova MY; Vilchevska KV; Doronin VA; Schmidt A; Hulin C; Leleu X; Esseltine DL; Venkatakrishnan K; Skee D; Feng H; Girgis S; Cakana A; van de Velde H; Deraedt W; Facon T; Moreau, Philippe; Karamanesht, Ievgenii I; et al
Academic Journal
Academic Journal
Devineni D; Janssen Research & Development, LLC, Raritan, NJ 08869, USA. DDevinen@its.jnj.com; Morrow L; Hompesch M; Skee D; Vandebosch A; Murphy J; Ways K; Schwartz S
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Academic Journal
Huang MQ; Janssen Research & Development, LLC, Pharmaceutical Companies of Johnson & Johnson, 1400 McKean Road, Spring House, PA 19477, USA. Electronic address: qingtao_huang@yahoo.com.; Kang L; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Wang W; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Skee D; Janssen Research & Development, LLC, Pharmaceutical Companies of Johnson & Johnson, 920 Rt 202, Raritan, NJ 08869, USA.; Chen M; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Lin ZJ; Frontage Laboratories Inc., 700 Pennsylvania Drive, Exton, PA 19341, USA.; Verhaeghe T; Janssen Research & Development, Turnhoutseweg 30, 2340 Beerse, Belgium.; Weng N; Janssen Research & Development, LLC, Pharmaceutical Companies of Johnson & Johnson, 1400 McKean Road, Spring House, PA 19477, USA.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101139554 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-376X (Electronic) Linking ISSN: 15700232 NLM ISO Abbreviation: J Chromatogr B Analyt Technol Biomed Life Sci Subsets: MEDLINE
Academic Journal
de Jong J; Janssen Research & Development San Diego, California.; Skee D; Janssen Research & Development Raritan, New Jersey.; Murphy J; Janssen Research & Development Raritan, New Jersey.; Sukbuntherng J; Pharmacyclics Inc. Sunnyvale, California.; Hellemans P; Janssen Research & Development Beerse, Belgium.; Smit J; Janssen Research & Development Beerse, Belgium.; de Vries R; Janssen Research & Development Beerse, Belgium.; Jiao JJ; Janssen Research & Development Raritan, New Jersey.; Snoeys J; Janssen Research & Development Beerse, Belgium.; Mannaert E; Janssen Research & Development Beerse, Belgium.
Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2052-1707 (Print) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: PubMed not MEDLINE
Academic Journal
Devineni D; Janssen Research & Development, LLC, Raritan, NJ, USA.; Manitpisitkul P; Janssen Research & Development, LLC, Raritan, NJ, USA.; Murphy J; Janssen Research & Development, LLC, Raritan, NJ, USA.; Skee D; Janssen Research & Development, LLC, Raritan, NJ, USA.; Wajs E; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Mamidi RN; Janssen Research & Development, LLC, Raritan, NJ, USA.; Tian H; Janssen Research & Development, LLC, Raritan, NJ, USA.; Vandebosch A; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Wang SS; Janssen Research & Development, LLC, Raritan, NJ, USA.; Verhaeghe T; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Stieltjes H; Janssen Research & Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.; Usiskin K; Janssen Research & Development, LLC, Raritan, NJ, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Academic Journal
Scheers E; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Leclercq L; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; de Jong J; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Bode N; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Bockx M; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Laenen A; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Cuyckens F; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Skee D; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Murphy J; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Sukbuntherng J; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.).; Mannens G; Pharmacokinetics, Dynamics and Metabolism, Janssen R&D, Beerse, Belgium (E.S., L.L., M.B., A.L., F.C., G.M.); Clinical Pharmacology, Janssen R&D, San Diego, California (J.d.J.); Pre-Clinical Project Development, Janssen R&D, Beerse, Belgium (N.B.); Clinical Pharmacology, Janssen R&D, Raritan, New Jersey (D.S., J.M.); and Pharmacyclics, Sunnyvale, California (J.S.) gmannens@its.jnj.com.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9421550 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-009X (Electronic) Linking ISSN: 00909556 NLM ISO Abbreviation: Drug Metab Dispos Subsets: MEDLINE
Academic Journal
Devineni D; Manitpisitkul P; Vaccaro N; Bernard A; Skee D; Mamidi RN; Tian H; Weiner S; Stieltjes H; Sha S; Rothenberg P
Publisher: Dustri-Verlag Dr. K. Feistle Country of Publication: Germany NLM ID: 9423309 Publication Model: Print Cited Medium: Print ISSN: 0946-1965 (Print) Linking ISSN: 09461965 NLM ISO Abbreviation: Int J Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Barbour A; Department of Pharmaceutics, University of Florida, 1600 SW Archer Road, Gainesville, FL 32610, USA.; Schmidt S; Sabarinath SN; Grant M; Seubert C; Skee D; Murthy B; Derendorf H
Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE
Academic Journal
Abrams LS; Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Raritan, New Jersey 08869, USA. labrams@prius.jnj.com; Skee D; Natarajan J; Wong FA
Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print Cited Medium: Print ISSN: 0015-0282 (Print) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Skee D
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어